CERTIFICATE

IMPACT FACTOR 2021

Subject Area

  • Life Sciences / Biology
  • Architecture / Building Management
  • Asian Studies
  • Business & Management
  • Chemistry
  • Computer Science
  • Economics & Finance
  • Engineering / Acoustics
  • Environmental Science
  • Agricultural Sciences
  • Pharmaceutical Sciences
  • General Sciences
  • Materials Science
  • Mathematics
  • Medicine
  • Nanotechnology & Nanoscience
  • Nonlinear Science
  • Chaos & Dynamical Systems
  • Physics
  • Social Sciences & Humanities

Why Us? >>

  • Open Access
  • Peer Reviewed
  • Rapid Publication
  • Life time hosting
  • Free promotion service
  • Free indexing service
  • More citations
  • Search engine friendly

A sociodemographic study to evaluate the pattern of adverse drug reaction with new inactive or injectable polio vaccine and awareness about ipv

Author: 
Dr. Archana G. Dhavalshankh, Dr. Ahilya Kanase and Dr. Ganesh P. Dhavalshankh
Subject Area: 
Life Sciences
Abstract: 

The introduction of one dose of IPV into routine immunization programme is to mitigate risks associated with OPV withdrawal and potential reintroduction of poliovirus. In polio Eradication and End Game Strategic Plan, SAGE (Strategic Advisory Group Of Experts) on Immunization has recommended that all OPV using countries should introduce one dose of IPV into routine immunization schedule and administer that dose at or >14 weeks of age in addition to the 3 to 4 doses of OPV in primary series. India has incorporated IPV under National Immunization Programme in November 2015. Our study focused on awareness about IPV among people and health care workers. We carried out this study to collect sociodemographic profile for monitoring use, and coverage of IPV, to identify the pattern of adverse drug effects with new IPV, to assess the knowledge and awareness about IPV in society. Though our study showed that with 97.7 to 100 % coverage of immunization with IPV, only minor local complaints after IPV administration but no single adverse events reported or documented either by the parent or by the health care persons. Our study information is useful to find how effectively immunization targets have met and -how efficiently the IPV is being used. Detected adverse drug reactions with IPV would be helpful -to maintain Universal Immunization Programme. This pilot project was undertaken with provision of use of IPV in routine and campaigns to assess vaccine acceptance to support country policy decisions; and ecologic studies in developing countries switching to all-IPV routine immunization schedules to evaluate potential emergence of cVDPVs and risk of WPV importations.

PDF file: 

CALL FOR PAPERS

 

ONLINE PAYPAL PAYMENT

IJMCE RECOMMENDATION

Advantages of IJCR

  • Rapid Publishing
  • Professional publishing practices
  • Indexing in leading database
  • High level of citation
  • High Qualitiy reader base
  • High level author suport

Plagiarism Detection

IJCR is following an instant policy on rejection those received papers with plagiarism rate of more than 20%. So, All of authors and contributors must check their papers before submission to making assurance of following our anti-plagiarism policies.

 

EDITORIAL BOARD

CHUDE NKIRU PATRICIA
Nigeria
Dr. Swamy KRM
India
Dr. Abdul Hannan A.M.S
Saudi Arabia.
Luai Farhan Zghair
Iraq
Hasan Ali Abed Al-Zu’bi
Jordanian
Fredrick OJIJA
Tanzanian
Firuza M. Tursunkhodjaeva
Uzbekistan
Faraz Ahmed Farooqi
Saudi Arabia
Eric Randy Reyes Politud
Philippines
Elsadig Gasoom FadelAlla Elbashir
Sudan
Eapen, Asha Sarah
United State
Dr.Arun Kumar A
India
Dr. Zafar Iqbal
Pakistan
Dr. SHAHERA S.PATEL
India
Dr. Ruchika Khanna
India
Dr. Recep TAS
Turkey
Dr. Rasha Ali Eldeeb
Egypt
Dr. Pralhad Kanhaiyalal Rahangdale
India
DR. PATRICK D. CERNA
Philippines
Dr. Nicolas Padilla- Raygoza
Mexico
Dr. Mustafa Y. G. Younis
Libiya
Dr. Muhammad shoaib Ahmedani
Saudi Arabia
DR. MUHAMMAD ISMAIL MOHMAND
United State
DR. MAHESH SHIVAJI CHAVAN
India
DR. M. ARUNA
India
Dr. Lim Gee Nee
Malaysia
Dr. Jatinder Pal Singh Chawla
India
DR. IRAM BOKHARI
Pakistan
Dr. FARHAT NAZ RAHMAN
Pakistan
Dr. Devendra kumar Gupta
India
Dr. ASHWANI KUMAR DUBEY
India
Dr. Ali Seidi
Iran
Dr. Achmad Choerudin
Indonesia
Dr Ashok Kumar Verma
India
Thi Mong Diep NGUYEN
France
Dr. Muhammad Akram
Pakistan
Dr. Imran Azad
Oman
Dr. Meenakshi Malik
India
Aseel Hadi Hamzah
Iraq
Anam Bhatti
Malaysia
Md. Amir Hossain
Bangladesh
Ahmet İPEKÇİ
Turkey
Mirzadi Gohari
Iran